Site icon pharmaceutical daily

Charles River Laboratories to Present at Jefferies and Goldman Sachs Investor Conferences

WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL–Charles River Laboratories International, Inc. (NYSE: CRL) announced
today that it will present at two upcoming investor conferences,
including:

Management will present an overview of Charles River’s strategic focus
and business developments.

A live webcast of each presentation will be available through a link
that will be posted on the Investor Relations section of the Charles
River website at ir.criver.com.
A webcast replay will be accessible through the same website after each
presentation and will remain available for approximately two weeks.

About Charles River

Charles River provides essential products and services to help
pharmaceutical and biotechnology companies, government agencies and
leading academic institutions around the globe accelerate their research
and drug development efforts. Our dedicated employees are focused on
providing clients with exactly what they need to improve and expedite
the discovery, early-stage development and safe manufacture of new
therapies for the patients who need them. To learn more about our unique
portfolio and breadth of services, visit www.criver.com.

Contacts

Todd Spencer
Corporate Vice President, Investor Relations
781.222.6455
todd.spencer@crl.com

Exit mobile version